Antitumor binding, av8062 and docetaxel.

摘要

The invention refers to the antitumor and continuous combination of ave8062 or its salts and dodecanol, which is characterized in that ave8062 is taken by patients within the dose range of 10-50 mg / m2, and then another day every week, preferably 24 hours later. Dodecyl chloride was administered at doses between 50 and 120 mg / m2.